EKİNCİ, F. Et Al. 2021. Can Albumin Bilirubin Ratio and Inflammatory Prognostic Index Be A New Marker Determining Survival in Metastatic Pancreatic Cancer?. The Gulf journal of oncology , vol.1, no.36 , 45-52.

EKİNCİ, F., Sarı, D., Çelik, C., Dirican, A., ERDOĞAN, A. P., & Gökse, G., (2021). Can Albumin Bilirubin Ratio and Inflammatory Prognostic Index Be A New Marker Determining Survival in Metastatic Pancreatic Cancer?. The Gulf journal of oncology , vol.1, no.36, 45-52.

EKİNCİ, FERHAT Et Al. "Can Albumin Bilirubin Ratio and Inflammatory Prognostic Index Be A New Marker Determining Survival in Metastatic Pancreatic Cancer?," The Gulf journal of oncology , vol.1, no.36, 45-52, 2021

EKİNCİ, FERHAT Et Al. "Can Albumin Bilirubin Ratio and Inflammatory Prognostic Index Be A New Marker Determining Survival in Metastatic Pancreatic Cancer?." The Gulf journal of oncology , vol.1, no.36, pp.45-52, 2021

EKİNCİ, F. Et Al. (2021) . "Can Albumin Bilirubin Ratio and Inflammatory Prognostic Index Be A New Marker Determining Survival in Metastatic Pancreatic Cancer?." The Gulf journal of oncology , vol.1, no.36, pp.45-52.

@article{article, author={FERHAT EKİNCİ Et Al. }, title={Can Albumin Bilirubin Ratio and Inflammatory Prognostic Index Be A New Marker Determining Survival in Metastatic Pancreatic Cancer?}, journal={The Gulf journal of oncology}, year=2021, pages={45-52} }